08 May 2018 --- Takeda Pharmaceutical has reached a deal to buy Shire Plc. for US$62 billion in a move hoped to rapidly boost Takeda’s global standing as a biopharmaceutical leader. It is predicted to bring together Takeda and Shire’s complementary positions in gastroenterology (GI), neuroscience and more. Also, it may advance Shire’s portfolio with Takeda’s strong presence in emerging markets and Japan.